EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Epidemiology and determinants of dyslipidemia in Iranian population: Results from the PERSIAN cohort

Nazgol Motamed-Gorji, Sadaf G Sepanlou, Marjan Moallemian Isfahani, Ali Ahmadi, Meysam Alipour, Azizallah Dehghan iD, Pedram Ebrahimnejad, Mohhamad Reza Fattahi, Masoumeh Goddusi Johari, Zahra Jamali, Mahmoud Ali Kaykhaei, Seyyedadel Khoshbou Garebagh und 13 weitere

PLOS One · 17.07.2026 · 21 (7) · e0352516

DOI: 10.1371/journal.pone.0352516 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, online erschienen am 17.07.2026. Verfasst von Nazgol Motamed-Gorji und 24 weiteren Autor:innen. Beteiligte Einrichtung: Liver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Dyslipidemias. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Dyslipidemia is one of the main risk factors for cardiovascular diseases worldwide. The current study aimed to determine the prevalence and correlates of dyslipidemia in Iran, in addition to factors associated with receiving treatment and attaining treatment goals.

Methods

The current study used the data of a very large cross-sectional survey, Prospective Epidemiological Research Studies in IrAN (PERSIAN), including 163,770 Iranians aged 35–70 years from 18 distinct areas across Iran, between 2014 and 2020. Participants’ characteristics were recorded using validated questionnaires including biological samples, physical measurements, and self-reported information. Dyslipidemia was defined according to the Third Report of the Adult Treatment Panel. Triglycerides (TG), total cholesterol (TC), high-density lipoprotein (HDL) and low-density lipoprotein (LDL) were measured as components of dyslipidemia. We calculated participants’ 10-years cardiovascular risk using the World Health Organization risk charts to assess the eligibility for treatment and achievement of control. Multivariable logistic regression analyses were conducted to investigate the correlates of dyslipidemia, receiving treatment, and control.

Results

The mean age of participants was 49.4 (±9.1) years, among whom 55% were women and 70% were urban residents. The weighted prevalence of dyslipidemia was 73.2% (95% CI: 71.5–75.0%). High TG (40.4%, 36.9%−44.4%) and high TC (36.2%, 32.9%−39.4%) comprised the most prevalent components of dyslipidemia, followed by low HDL-C (32.1%, 25.8%−38.4%), high non-HDL-C (26.6%, 24.0%−29.1%), and high LDL-C (23.4%, 21.1%−25.7%). In multivariable logistic regression analysis, younger age, tobacco consumption, low physical activity, high BMI, diabetes, and hypertension were associated with low HDL-C and high TG. Older age, alcohol consumption, low physical activity, and high BMI were associated with high TC and high LDL-C. Women had higher likelihood of having abnormal levels for all components of dyslipidemia, except for high TG. Older age, high wealth score, high BMI, and low physical activity were associated with higher utilization of statin treatment. Good lipid control in those who were treated with statin was higher in males and diabetics.

Conclusion

The prevalence of dyslipidemia in Iranian population is extremely high, and certain groups are at higher risk of poor lipid control. Findings of this study highlight the necessity of developing a national guideline for management of dyslipidemia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DyslipidemiasIranHumansFemaleMiddle AgedMaleAdultAgedTriglyceridesPrevalenceCross-Sectional StudiesRisk FactorsProspective Studies

Substanzen

Triglycerides

Autor:innen und Institutionen

  • Liver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Digestive Disease Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Modeling in Health Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran.
  • Department of Nutrition, Shoushtar Faculty of Medical Sciences, Shoushtar, Iran.
  • Noncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran.
  • Department of Pharmaceutics, School of Pharmacy, Pharmaceutical Sciences Research Center, Hemoglobinopathy Institute, Mazandaran University of Medical Sciences, Sari, Iran.

ORCID-Profile: Azizallah Dehghan, Somaieh Matin, Azim Nejatizadeh, Reza Malekzadeh

Zitieren

APA

Motamed-Gorji, N., Sepanlou, S. G., Moallemian Isfahani, M., Ahmadi, A., Alipour, M., Dehghan, A., Ebrahimnejad, P., Fattahi, M. R., Goddusi Johari, M., Jamali, Z., Kaykhaei, M. A., Khoshbou Garebagh, S., Mansour-Ghanaei, F., Matin, S., Mirzaei, M., Moradi, Y., Nejatizadeh, A., Ostadrahimi, A., Rastegar, A., …, & Malekzadeh, R. (2026). Epidemiology and determinants of dyslipidemia in Iranian population: Results from the PERSIAN cohort. PLOS One, 21(7), e0352516. https://doi.org/10.1371/journal.pone.0352516

Vancouver

Motamed-Gorji N, Sepanlou SG, Moallemian Isfahani M, Ahmadi A, Alipour M, Dehghan A, et al. Epidemiology and determinants of dyslipidemia in Iranian population: Results from the PERSIAN cohort. PLOS One. 2026;21(7):e0352516. doi:10.1371/journal.pone.0352516

BibTeX
@article{MotamedGorji2026,
  author = {Motamed-Gorji, Nazgol and Sepanlou, Sadaf G and Moallemian Isfahani, Marjan and Ahmadi, Ali and Alipour, Meysam and Dehghan, Azizallah and Ebrahimnejad, Pedram and Fattahi, Mohhamad Reza and Goddusi Johari, Masoumeh and Jamali, Zahra and Kaykhaei, Mahmoud Ali and Khoshbou Garebagh, Seyyedadel and Mansour-Ghanaei, Fariborz and Matin, Somaieh and Mirzaei, Masoud and Moradi, Yousef and Nejatizadeh, Azim and Ostadrahimi, Alireza and Rastegar, Ayoob and Sedaghattalab, Moslem and Shakiba, Ebrahim and Eghtesad, Sareh and Mohammadi, Zahra and Poustchi, Hossein and Malekzadeh, Reza},
  title = {Epidemiology and determinants of dyslipidemia in Iranian population: Results from the PERSIAN cohort},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {7},
  pages = {e0352516},
  doi = {10.1371/journal.pone.0352516}
}
Kostenlos starten →